Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-320 is a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR-105, a fully human IgG1 mAb, which is in Phase II trials to target gram-negative bacteria P. aeruginosa; AR-101, a human IgM mAb, which is in Phase IIa clinical trials for the treatment of hospital-acquired pneumonia (HAP)and ventilator-associated pneumonia (VAP) caused by P. aeruginosa serotype O11; AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-501, an anti-infective therapy, which is in Phase I/IIa clinical trial to manage chronic lung infections in cystic fibrosis patients. In addition, it is developing AR-712 and AR-701, a cocktail of two fully human immunoglobulin 1, or IgG1, mAbs, which is in Phase I/II clinical for the treatment of mild to moderate non-hospitalized COVID-19 patients. Aridis Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Los Gatos, California.

Filer	Latest Filing Date	Share-Type	Shares	Market Value	Previously owned	Change
Aigh Capital Management Llc	2021-05-13	Shares	423.36K	2.50M	347.02K	76.34K
Aigh Capital Management Llc	2021-05-13	Shares	423.36K	2.50M	347.02K	76.34K
Roumell Asset Management, Llc	2021-05-14	Shares	222.22K	1.31M	0	222.22K
Roumell Asset Management, Llc	2021-05-14	Shares	222.22K	1.31M	0	222.22K
Vanguard Group Inc	2021-05-14	Shares	149.66K	883K	147.42K	2.23K
Vanguard Group Inc	2021-05-14	Shares	149.66K	883K	147.42K	2.23K
Worth Venture Partners, Llc	2021-05-17	Shares	105.41K	622K	87.93K	17.48K
Worth Venture Partners, Llc	2021-05-17	Shares	105.41K	622K	87.93K	17.48K
Minot Wealth Management Llc	2021-04-29	Shares	72.23K	426K	132.28K	-60.05K
Minot Wealth Management Llc	2021-04-29	Shares	72.23K	426K	132.28K	-60.05K
Blackrock Inc.	2021-05-07	Shares	26.38K	156K	23.68K	2.70K
Blackrock Inc.	2021-05-07	Shares	26.38K	156K	23.68K	2.70K
Wealth Architects, Llc	2023-08-02	Shares	14.08K	3.10K	14.08K	0
Wealth Architects, Llc	2023-08-02	Shares	14.08K	3.10K	14.08K	0
Perritt Capital Management Inc	2021-05-17	Shares	10.10K	60K	0	10.10K
Perritt Capital Management Inc	2021-05-17	Shares	10.10K	60K	0	10.10K
Wells Fargo & Company/Mn	2021-05-13	Shares	1.27K	7K	341	925
Wells Fargo & Company/Mn	2021-05-13	Shares	1.27K	7K	341	925
Citigroup Inc	2021-05-13	Shares	750	4K	750	0
Citigroup Inc	2021-05-13	Shares	750	4K	750	0
Morgan Stanley	2021-05-17	Shares	500	3K	0	500
Morgan Stanley	2021-05-17	Shares	500	3K	0	500
Bank Of America Corp /De/	2021-05-14	Shares	28	0	0	28
Bank Of America Corp /De/	2021-05-14	Shares	28	0	0	28
Tower Research Capital Llc ...	2021-05-17	Shares	0	0	653	-653
Tower Research Capital Llc ...	2021-05-17	Shares	0	0	653	-653
Ubs Group Ag	2021-05-12	Shares	0	0	454	-454
Ubs Group Ag	2021-05-12	Shares	0	0	454	-454
Jpmorgan Chase & Co	2021-02-19	Shares	0	0	4	-4
Victory Capital Management Inc	2020-08-07	Shares	0	0	1.03K	-1.03K
Victory Capital Management Inc	2020-08-07	Shares	0	0	1.03K	-1.03K
Jpmorgan Chase & Co	2021-02-19	Shares	0	0	4	-4
Federated Hermes, Inc.	2021-05-13	Shares	0	0	472	-472
Federated Hermes, Inc.	2021-05-13	Shares	0	0	472	-472
Concourse Financial Group S...	2021-05-13	Shares	0	0	0	0
Concourse Financial Group S...	2021-05-13	Shares	0	0	0	0
Millennium Management Llc	2021-02-16	Shares	0	0	11.33K	-11.33K
Millennium Management Llc	2021-02-16	Shares	0	0	11.33K	-11.33K

NASDAQ:ARDS

Aridis Pharmaceuticals, Inc.

Market Cap

2.94M

Beta: 0.99

Volume Today

174.90K

Avg: 997.59K

PE Ratio

−4.42

PFCF: −0.20

Institutional trades

Institutional Ownership

Current holdings institutionals